Congruently, pharmacological inhibition of CSF1R (BLZ945) in a PDGFB-driven GBM mouse model skewed macrophages to an immune-stimulating state blocking glioma progression and enhancing survival without depleting microglial cells (95). This evidence concerns the gene PDGFB and glioblastoma.